Detalhe da pesquisa
1.
The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers.
J Gen Intern Med
; 37(1): 168-175, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664188
2.
The importance of association of comorbidities on COVID-19 outcomes: a machine learning approach.
Curr Med Res Opin
; 38(4): 501-510, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35037799
3.
Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry.
Ann Med
; 53(1): 103-116, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33063540
4.
Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry.
PLoS One
; 16(2): e0247422, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33606820
5.
[Integral control of risk factors in patients of high and very high cardiovascular risk in Spain. CIFARC project]. / Control integral de los factores de riesgo en pacientes de alto y muy alto riesgo cardiovascular en España. Estudio CIFARC.
Med Clin (Barc)
; 124(2): 44-9, 2005 Jan 22.
Artigo
em Espanhol
| MEDLINE | ID: mdl-15691431
6.
[Decrease of total hemorrhage with reduced doses of enoxaparin in high risk unstable angina. ENHNFAI study. (Enoxaparin vs non-fractionated heparin in unstable angina). Preliminary report]. / Disminución de hemorragias totales con dosis reducidas de enoxaparina en angina inestable de alto riesgo. Estudio ENHNFAI. (ENoxaparina vs Heparina No Fraccionada en Angina inestable). Informe preliminar.
Arch Cardiol Mex
; 72(3): 209-19, 2002.
Artigo
em Espanhol
| MEDLINE | ID: mdl-12418296